| CAS ID: | 122795-43-1 |
| Molecular Formula: | C16H26GdN5O8 |
| Molecular Weight: | 591.7 g/mol |
| Monoisotopic Mass: | 592.113 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | S-041 | GADODIAMIDE | OMNISCAN | GDDTPA-BMA |
| Analysis: | Drug repositioning mechanism analysis |
| InChI: | InChI=1S/C16H29N5O8.Gd.H2O/c1-17-12(22)7-20(10-15(26)27)5-3-19(9-14(24)25)4-6-21(11-16(28)29)8-13(23)18-2;;/h3-11H2,1-2H3,(H,17,22)(H,18,23)(H,24,25)(H,26,27)(H,28,29);;1H2/q;+3;/p-3 | See All |
| InChI Key: | XPCLDSMKWNNKOM-UHFFFAOYSA-K | |
| Smiles: | CNC(=O)CN(CCN(CCN(CC(=O)NC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].O.[Gd+3] | See All |
| Molfile: | Download |
Trial Record 1
| ClinicalTrial ID | NCT00908310 | Disease | Renal fibrosis |
| Phase | Phase 4 | Status | Completed |
| First Received | May 25, 2009 | Last Verified | July 17, 2014 |
| Sponsor | GE Healthcare | ||
| PubChem: | 60754 |
| ChEMBL: | CHEMBL1200346 |